Company: SMNR
Filing Date: 2025-10-21
Form Type: S-1
Source: 0001193125-25-245178
Chunk: 457

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-10-21
Form: S-1
Chunk 457
---
000 |   |

Note 11. Subsequent Events The Company has completed an evaluation of all subsequent events through the date these financial statements were issued, to ensure these financial statements include appropriate disclosure of events both recognized in the financial statements and events which occurred but were not recognized in the financial statements. The Company has concluded that no events or transactions have occurred that require disclosure. Pursuant to the Merger Agreement Amendment, among other things, parties agreed to (i) modify certain covenants of the parties to address the potential delisting of the Denali Securities from the Nasdaq Capital F-84

Market, (ii) extend the Outside Date to September 30, 2025, and (iii) require Denali to amend its organizational documents to extend the period of time within which Denali can complete a business combination to December 11, 2025, or such other date that is mutually agreed to by the Company and Denali.

<div align='center'>F-85</div>

SEMNUR PHARMACEUTICALS, INC. CONDENSED BALANCE SHEETS (In thousands, except for par value and share amounts) (Unaudited)

| ASSETS                                                                                                                                              
 Current assets:                                                                                                                                     |     | June 30,2025 |          |   |     | December 31, 
 2024         |          |   |
|:----------------------------------------------------------------------------------------------------------------------------------------------------|:----|:-------------|---------:|:--|:----|:-------------|---------:|:--|
| Cash and cash equivalents                                                                                                                           |     | $            |       55 |   |     | $            |       12 |   |
| Prepaid expenses                                                                                                                                    |     |              |        — |   |     |              |        2 |   |
| Other current assets                                                                                                                                |     |              |    8,335 |   |     |              |    5,981 |   |
| Total current assets:                                                                                                                               |     |              |    8,390 |   |     |              |    5,995 |   |
| Property and equipment, net                                                                                                                         |     |              |      689 |   |     |              |      689 |   |
| Total assets                                                                                                                                        |     | $            |    9,079 |   |     | $            |    6,684 |   |
| LIABILITIES AND STOCKHOLDERS’ DEFICIT                                                                                                               |     |              |          |